Amplia – Talk Bio

Actionable Insights Powered by AI

Narmafotinib Large-Scale Manufacture Complete by Amplia Therapeutics

narmafotinib; Amplia Therapeutics; large-scale manufacture; Phase 3 readiness; pancreatic cancer; GMP